Findings presented at the 2023 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) were the first to compare the two drugs for relapsing-remitting multiple sclerosis.
Marco Meglio
Advertisement
Articles by Marco Meglio
The phase 2 TOPAZ trial demonstrated treatment is safe and improves motor function in patients with SMA.
Advertisement
Latest Updated Articles
Phase 2 Trial Drug Apitegromab Shows Progress for Spinal Muscular Atrophy PatientsPublished: March 17th 2021 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Insights from the AMCP Nexus 2025 Meeting
2
The Shift in Star Ratings That Health Plans Can't Ignore
3
Celiac Disease and Thyroid Disease in Adolescence Linked to the Development of Type 1 Diabetes in Adulthood
4
Fulton County Leaders Discuss Closing Health Gaps and Strengthening Behavioral Health Systems
5
